Chris Crucitti is a 20+ year seasoned life sciences and clinical services/technology executive. As Clinical Ink’s Chief Commercial Officer (CCO), Chris supports our continued growth, optimizing go-to-market strategies and building a scalable customer service approach.
With a strong track record of value creation, Chris consistently drives significant top-line and bottom-line growth for all stakeholders. He is notably accomplished in building teams and creating high-level, cross-function customer success, performance, and effectiveness.
Prior to joining Clinical Ink, Chris served as CCO at Signant Health, leading commercial functions for their patient-centric clinical technology solutions. Chris brings significant experience and expertise in the clinical and R&D domains, including full-service CRO, data and analytics, eClinical technology solutions, strategic resourcing, consulting, and commercial. He has a track record of driving significant revenue and profitability growth while maintaining a high level of customer service and quality delivery. Chris holds a master’s degree from American University and a bachelor’s degree from Ithaca College.